Waijer SW, Vart P, Cherney DZI, Chertow GM, et al. Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial. Diabetologia 2022;65:1085-1097.
PMID: 35445820